Sign in

CIK 0001728328

  • Emerging growth company

Mentari Therapeutics, Inc.

Sign in to watch
Ticker
MTRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
981428279
Phone
+1 781-887-5080
Business address
221 CRESCENT STREET, BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
InMed Pharmaceuticals Inc.
Open-market buys, last 90 days
$238,371
in 7 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ADAR1 Capital Management, LLC +$238K 10% owner 7 filings
Date Insider Transaction Shares Price Value Owned after
2025-12-19 Jagpal Netta Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +18,000 24,250
2025-12-19 WOUDENBERG MICHAEL Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +18,000 25,445
2025-12-19 Bathery John Steven Director Grant or award · Employee Stock Option (Right to Buy) +1,750 5,250
2025-12-19 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Grant or award · Employee Stock Option (Right to Buy) +13,000 18,280
2025-12-19 ADAMS ERIC A President & CEO Grant or award · Employee Stock Option (Right to Buy) +35,000 49,050
2025-12-19 HULL ANDREW Director Grant or award · Employee Stock Option (Right to Buy) +1,750 2,711
2025-12-15 HULL ANDREW Director Other disposition · Employee Stock Option (Expiration) −14 961
2025-12-15 ADAMS ERIC A President & CEO Other disposition · Employee Stock Option (Expiration) −250 14,050
2025-12-15 WOUDENBERG MICHAEL Chief Operating Officer Other disposition · Employee Stock Option (Expiration) −60 7,445
2025-12-15 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Other disposition · Employee Stock Option (Expiration) −70 5,280
2025-10-17 Klompas Neil A Director Grant or award · Employee Stock Option (Right to Buy) +3,500 3,500
2025-01-11 HULL ANDREW Director Other disposition · Employee Stock Option (Expiration) −2 975
2024-12-20 Johnson Shane Aaron Sr VP & General Manager Grant or award · Employee Stock Option (Right to Buy) +1,500 3,900
2024-12-20 Jagpal Netta Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +3,750 6,250
2024-12-20 Lemerond Nicole Director Grant or award · Employee Stock Option (Right to Buy) +550 975
2024-12-20 WOUDENBERG MICHAEL Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +3,750 7,505
2024-12-20 Grove Janet P Director Grant or award · Employee Stock Option (Right to Buy) +550 975
2024-12-20 HSU ERIC C Sr. VP, Pre-Clinical Res/Dev Grant or award · Employee Stock Option (Right to Buy) +2,750 5,350
2024-12-20 ADAMS ERIC A President & CEO Grant or award · Employee Stock Option (Right to Buy) +6,250 14,300
2024-12-20 Baldasare Bryan T Director Grant or award · Employee Stock Option (Right to Buy) +550 975

Page 4 of 9 · 173 trades